Acyclovir and Emgality drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Acyclovir (acyclovir) and Emgality (galcanezumab-gnlm). Common drug interactions include nephrolithiasis among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Emgality. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Acyclovir?
Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.
What is Emgality?
Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.
22 people who take Acyclovir and Emgality together, and have interactions are studied.

What are the common drug interactions of Acyclovir and Emgality, by gender? *:
female:
- Nephrolithiasis (calculi in the kidneys)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Feeling hot
- Impaired gastric emptying
- Infection
- Infusion related reaction
- Infusion site erythema (reddening of the skin at infusion site)
- Infusion site haemorrhage (bleeding from infusion site)
- Infusion site pain
male:
- Drug ineffective
- Dry mouth
- Gallbladder disorder
- Migraine (headache)
- Muscular weakness (muscle weakness)
- Pneumonia
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
What are the common drug interactions of Acyclovir and Emgality, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Asthenia (weakness)
- Contusion (a type of hematoma of tissue in which capillaries)
- Cough
- Decreased appetite
- Dizziness
- Fatigue (feeling of tiredness)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hepatic enzyme increased
- Hepatic failure (liver failure)
- Irritability
30-39:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anxiety
- Contusion (a type of hematoma of tissue in which capillaries)
- Decreased activity
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Loss of consciousness
- Pruritus (severe itching of the skin)
- Rash pruritic (redness with itching)
40-49:
- Chronic kidney disease
- Pain
- Abdominal pain
- Abdominal pain upper
- Back pain
- Blood creatinine increased
- Drug ineffective
- Emotional distress
- Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
- Fungal infection
50-59:
- Fatigue (feeling of tiredness)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Contusion (a type of hematoma of tissue in which capillaries)
- Feeling hot
- Headache (pain in head)
- Impaired gastric emptying
- Infection
- Infusion related reaction
- Infusion site erythema (reddening of the skin at infusion site)
60+:
- Arrhythmia (irregular heartbeat)
- Aura
- Pneumonia
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Diarrhoea
- Muscle spasms (muscle contraction)
- Drug ineffective
- Dry mouth
- Eye pain
- Headache (pain in head)
What are the existing conditions these people have? *
- Asthma: 6 people, 27.27%
- Migraine (headache): 6 people, 27.27%
- High Blood Pressure: 5 people, 22.73%
- Depression: 5 people, 22.73%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 22.73%
- Hypersensitivity: 5 people, 22.73%
- Stress And Anxiety: 5 people, 22.73%
- High Blood Cholesterol: 5 people, 22.73%
- Immunodeficiency Common Variable: 5 people, 22.73%
- Nausea (feeling of having an urge to vomit): 4 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Acyclovir and Emgality?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Acyclovir and Emgality:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Acyclovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Emgality:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Acyclovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emgality and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on acyclovir and galcanezumab-gnlm (the active ingredients of Acyclovir and Emgality, respectively), and Acyclovir and Emgality (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Colchicine for Gout? - a second ago
- Drug interactions of Cozaar and Lotronex - 6 seconds ago
- Drug interactions of Profen and Tambocor - 8 seconds ago
- Could Hydroxyzine cause Hepatocellular Damage Aggravated? - 13 seconds ago
- Could Pantoprazole cause Temperature Intolerance? - 23 seconds ago
- Drug interactions of Mekinist and Naproxen - 25 seconds ago
- Could Valproic Acid cause Hepatic Enzyme Increased? - 26 seconds ago
- Cataplexy and Glaucoma - 26 seconds ago
- Could Asacol Hd cause Pain In Extremity? - 27 seconds ago
- Could Fosfomycin Tromethamine cause Fainting? - 31 seconds ago